Research
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
Jody Corey-Bloom, Tanya Wolfson, Anthony Gamst, Shelia Jin, Thomas D. Marcotte, Heather Bentley and Ben Gouaux
CMAJ July 10, 2012 184 (10) 1143-1150; DOI: https://doi.org/10.1503/cmaj.110837
Jody Corey-Bloom
From the Departments of Neurosciences (Corey-Bloom), Biostatistics (Wolfson, Gamst, Jin) and Psychiatry (Marcotte, Bentley); and the Center for Medicinal Cannabis Research (Marcotte, Bentley, Gouaux), University of California, San Diego, La Jolla, Calif.
MD PhDTanya Wolfson
From the Departments of Neurosciences (Corey-Bloom), Biostatistics (Wolfson, Gamst, Jin) and Psychiatry (Marcotte, Bentley); and the Center for Medicinal Cannabis Research (Marcotte, Bentley, Gouaux), University of California, San Diego, La Jolla, Calif.
MAAnthony Gamst
From the Departments of Neurosciences (Corey-Bloom), Biostatistics (Wolfson, Gamst, Jin) and Psychiatry (Marcotte, Bentley); and the Center for Medicinal Cannabis Research (Marcotte, Bentley, Gouaux), University of California, San Diego, La Jolla, Calif.
PhDShelia Jin
From the Departments of Neurosciences (Corey-Bloom), Biostatistics (Wolfson, Gamst, Jin) and Psychiatry (Marcotte, Bentley); and the Center for Medicinal Cannabis Research (Marcotte, Bentley, Gouaux), University of California, San Diego, La Jolla, Calif.
MD MPHThomas D. Marcotte
From the Departments of Neurosciences (Corey-Bloom), Biostatistics (Wolfson, Gamst, Jin) and Psychiatry (Marcotte, Bentley); and the Center for Medicinal Cannabis Research (Marcotte, Bentley, Gouaux), University of California, San Diego, La Jolla, Calif.
PhDHeather Bentley
From the Departments of Neurosciences (Corey-Bloom), Biostatistics (Wolfson, Gamst, Jin) and Psychiatry (Marcotte, Bentley); and the Center for Medicinal Cannabis Research (Marcotte, Bentley, Gouaux), University of California, San Diego, La Jolla, Calif.
BABen Gouaux
From the Departments of Neurosciences (Corey-Bloom), Biostatistics (Wolfson, Gamst, Jin) and Psychiatry (Marcotte, Bentley); and the Center for Medicinal Cannabis Research (Marcotte, Bentley, Gouaux), University of California, San Diego, La Jolla, Calif.
BAData supplements
Related Articles
- (2012). Highlights. CMAJ, 184(10), 1119. Accessed April 18, 2024. Retrieved from http://www.cmaj.ca/content/184/10/1119.
In this issue
Article tools
Respond to this article
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
Jody Corey-Bloom, Tanya Wolfson, Anthony Gamst, Shelia Jin, Thomas D. Marcotte, Heather Bentley, Ben Gouaux
CMAJ Jul 2012, 184 (10) 1143-1150; DOI: 10.1503/cmaj.110837
Jump to section
Related Articles
Cited By...
- Patient Reported Outcomes of Medical Cannabis for Managing Pain in Charcot-Marie-Tooth Disease
- Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials
- Working With Clients Who Opt to Use Marijuana as an Alternative Treatment for Chronic Health Conditions
- Cannabis for pain in orthopedics: a systematic review focusing on study methodology
- The Misclassification of Medical Marijuana
- Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials
- Prescrire du cannabis fume pour la douleur chronique non cancereuse: Recommandations preliminaires
- Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- Should doctors prescribe cannabinoids?
- Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology